- Chemical name: 5-formyltetrahydrofolate (5-FTHF)
- Also known as: Leucovorin (pharmaceutical form), citrovorum factor
- Key property: Active folate — does NOT require DHFR for bioactivity
- Metabolic role: One-carbon unit donor for DNA synthesis + methylation cycle
- Key research area: Cerebral folate deficiency, ASD, MTHFR variants
- Format: Oral capsule — shelf-stable, no reconstitution
01 What Is Folinic Acid?
Folinic acid (5-formyltetrahydrofolate, 5-FTHF) is the stable, biologically active form of folate that enters one-carbon metabolism without requiring conversion by dihydrofolate reductase (DHFR). It is commercially available as leucovorin (the calcium salt used in cancer chemotherapy rescue protocols) but is increasingly studied as a standalone research compound in neurological, methylation, and metabolic contexts.
While folic acid (the synthetic oxidised form used in most supplements and food fortification) must be reduced twice by DHFR before becoming metabolically active, folinic acid bypasses this enzymatic bottleneck. This distinction is critical in populations with reduced DHFR activity, MTHFR polymorphisms, or conditions where folate transport or metabolism is impaired.
02 One-Carbon Metabolism — Why It Matters
One-carbon metabolism refers to the biochemical network that transfers single-carbon (methyl, formyl, methylene) units via tetrahydrofolate (THF) cofactors. This system is central to:
- DNA synthesis: 5,10-methyleneTHF donates a carbon for thymidylate synthesis (dTMP from dUMP via thymidylate synthase) and for purine synthesis (10-formylTHF)
- Methylation (methionine cycle): 5-MTHF donates a methyl group to homocysteine → methionine (via methionine synthase + B12); methionine → SAM (the universal methyl donor for DNA methylation, histone methylation, and hundreds of enzymatic reactions)
- Mitochondrial function: Serine/glycine interconversion and mitochondrial folate metabolism support the electron transport chain indirectly
- Neurotransmitter synthesis: Folate-mediated BH4 (tetrahydrobiopterin) synthesis supports dopamine, serotonin, and norepinephrine production
Folinic acid (5-FTHF) is metabolically flexible — it can be converted to 5-MTHF (for the methionine cycle), 5,10-methyleneTHF (for thymidylate synthesis), or 10-formylTHF (for purine synthesis). This positions folinic acid as a more versatile one-carbon donor than 5-MTHF, which is specifically channelled toward the methionine cycle.
03 The DHFR Bypass — Research Significance
Dihydrofolate reductase (DHFR) is the enzyme responsible for reducing folic acid (fully oxidised) → dihydrofolate (DHF) → tetrahydrofolate (THF). Several conditions impair this step:
- DHFR polymorphisms: Common variants reduce enzyme efficiency; high folic acid intake can saturate reduced DHFR capacity, leading to accumulation of unmetabolised folic acid (UMFA)
- Methotrexate treatment: Methotrexate is a DHFR inhibitor used in chemotherapy and autoimmune disease — folinic acid (leucovorin rescue) bypasses the block to restore THF pools in normal cells
- High folic acid load: Fortification and supplementation create folic acid loads that may exceed DHFR capacity, particularly in children and pregnant women, potentially causing UMFA-mediated NK cell impairment
In research models studying folate metabolism, folinic acid provides a clean entry point into the THF pool without the DHFR conversion variable — enabling cleaner experimental design than folic acid.
04 Cerebral Folate Deficiency Research
- Population: Children with ASD and FRα (folate receptor alpha) autoantibodies (n=48)
- Intervention: High-dose folinic acid (2 mg/kg/day, max 50 mg/day) vs placebo, 12 weeks
- Primary outcome: Verbal communication (VABS-II)
- Result: Significant improvement in verbal communication in folinic acid group (p=0.0008)
- Responders: Higher response rate in children with positive FRα antibodies
Cerebral folate deficiency (CFD) is caused by autoantibodies against folate receptor alpha (FRα) — the transporter that moves 5-MTHF across the choroid plexus into the CSF. When FRα is blocked, CNS folate falls despite normal serum levels. Folinic acid can partially bypass FRα-mediated transport via alternative folate transporters (PCFT, RFC), restoring CSF folate and supporting neurotransmitter synthesis.
05 MTHFR Polymorphism Research Context
| Folate Form | Requires DHFR? | Requires MTHFR? | Research Use |
|---|---|---|---|
| Folic acid | Yes (2× reduction) | Yes (→5-MTHF) | May accumulate as UMFA if DHFR impaired |
| Folinic acid (5-FTHF) | No | Yes (→5-MTHF) | Preferred for DHFR-impaired models |
| 5-MTHF (methylfolate) | No | No (already converted) | Best for methionine cycle research; limited to this branch |
| THF (tetrahydrofolate) | No | Yes (→5-MTHF) | Unstable; not used in supplementation research |
MTHFR C677T homozygotes have ~30–65% reduced enzyme activity. These individuals convert less folate to 5-MTHF — increasing homocysteine and reducing methylation capacity. Research in MTHFR-variant models typically uses 5-MTHF (to bypass the impaired step directly) or folinic acid (to provide a flexible THF pool that can support both methylation and DNA synthesis branches).
06 Frequently Asked Questions
What is Folinic Acid and how does it differ from Folic Acid?
Folinic acid (5-formyltetrahydrofolate, also known as leucovorin or 5-FTHF) is the metabolically active form of folate that does not require conversion by DHFR (dihydrofolate reductase) to become bioactive. Folic acid (the synthetic oxidised form) must first be reduced by DHFR to dihydrofolate, then again to tetrahydrofolate (THF), before entering one-carbon metabolism. In individuals with DHFR polymorphisms, MTHFR variants, or conditions impairing folate metabolism, folic acid may accumulate unconverted. Folinic acid bypasses the DHFR step entirely.
What is one-carbon metabolism and why does folinic acid matter for it?
One-carbon metabolism refers to the transfer of single-carbon units via folate cofactors. This system supports: DNA synthesis (via thymidylate and purine synthesis), methylation reactions (via methionine cycle — producing SAM, the universal methyl donor), and mitochondrial metabolism (serine/glycine interconversion). Folinic acid enters this cycle directly as 5-FTHF, contributing one-carbon units without requiring DHFR conversion. Defects in one-carbon metabolism underlie neural tube defects, cardiovascular disease, neuropsychiatric conditions, and impaired detoxification capacity.
What is cerebral folate deficiency and how is folinic acid used in research?
Cerebral folate deficiency (CFD) is a neurological condition where 5-methyltetrahydrofolate (5-MTHF) levels in the cerebrospinal fluid are low despite normal or elevated serum folate. It is caused by folate receptor autoantibodies (FRα antibodies) that block transport across the blood-brain barrier. CFD has been identified in a subset of autism spectrum disorder, Rett syndrome, and mitochondrial disease patients. High-dose folinic acid is studied as a research intervention because it can restore CSF folate via alternative transport mechanisms. Published RCT data (Frye et al., JAMA Pediatrics 2018) showed improvement in verbal communication in ASD children with FRα antibodies treated with folinic acid.
How does MTHFR polymorphism affect folate metabolism?
MTHFR (methylenetetrahydrofolate reductase) converts 5,10-methyleneTHF to 5-methylTHF (the dominant circulating form of folate). Common polymorphisms C677T and A1298C reduce MTHFR enzyme activity by 30–65%. Reduced MTHFR activity impairs methionine cycle function (less SAM for methylation), reduces DNA synthesis efficiency, and may increase homocysteine. Folinic acid is preferred over folic acid in research models of MTHFR impairment because it bypasses the DHFR step and can support THF pool replenishment via direct metabolic entry.
What is the difference between Folinic Acid and Methylfolate (5-MTHF)?
5-MTHF (methylfolate/levomefolate) is the final product of folate metabolism — it donates its methyl group to homocysteine (forming methionine) via methionine synthase, consuming B12 as cofactor. Folinic acid (5-FTHF) is an earlier intermediate that can be converted to multiple THF forms including 5-MTHF, 10-formylTHF (for purine synthesis), and 5,10-methyleneTHF (for thymidylate synthesis). Folinic acid is therefore more metabolically flexible — it can feed multiple branches of one-carbon metabolism — while 5-MTHF is specifically channelled toward the methionine cycle.
Related research: